- Home
- BIIB vs WDC Comparison
BIIB vs WDC Comparison
Compare BIIB & WDC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BIIB
- WDC
- Stock Information
- Founded
- BIIB 1978
- WDC 1970
- Country
- BIIB United States
- WDC United States
- Employees
- BIIB N/A
- WDC N/A
- Industry
- BIIB Biotechnology: Pharmaceutical Preparations
- WDC Electronic Components
- Sector
- BIIB Health Care
- WDC Technology
- Exchange
- BIIB Nasdaq
- WDC Nasdaq
- Market Cap
- BIIB 18.8B
- WDC 18.1B
- IPO Year
- BIIB 1991
- WDC N/A
- Fundamental
- Price
- BIIB $132.82
- WDC $66.05
- Analyst Decision
- BIIB Buy
- WDC Buy
- Analyst Count
- BIIB 27
- WDC 21
- Target Price
- BIIB $188.17
- WDC $67.10
- AVG Volume (30 Days)
- BIIB 1.3M
- WDC 6.6M
- Earning Date
- BIIB 07-31-2025
- WDC 07-30-2025
- Dividend Yield
- BIIB N/A
- WDC 0.61%
- EPS Growth
- BIIB 26.39
- WDC N/A
- EPS
- BIIB 10.12
- WDC 4.55
- Revenue
- BIIB $9,816,400,000.00
- WDC $15,605,000,000.00
- Revenue This Year
- BIIB N/A
- WDC N/A
- Revenue Next Year
- BIIB N/A
- WDC $7.93
- P/E Ratio
- BIIB $13.13
- WDC $21.81
- Revenue Growth
- BIIB 1.59
- WDC 123.41
- 52 Week Low
- BIIB $110.04
- WDC $28.83
- 52 Week High
- BIIB $238.00
- WDC $66.83
- Technical
- Relative Strength Index (RSI)
- BIIB 59.57
- WDC 87.57
- Support Level
- BIIB $123.90
- WDC $62.94
- Resistance Level
- BIIB $134.75
- WDC $64.34
- Average True Range (ATR)
- BIIB 3.50
- WDC 1.52
- MACD
- BIIB 0.28
- WDC 0.27
- Stochastic Oscillator
- BIIB 83.71
- WDC 94.02
About BIIB Biogen Inc.
Biogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug Avonex and Idec's cancer drug Rituxan. Today, Rituxan and next-generation antibody Gazyva (oncology) and Ocrevus (multiple sclerosis) are marketed via a collaboration with Roche. Biogen markets several multiple sclerosis drugs including Plegridy, Tysabri, Tecfidera, and Vumerity. Biogen's newer products include Spinraza (SMA, with partner Ionis), Leqembi (Alzheimers, with partner Eisai), Skyclarys (Friedreich's Ataxia, Reata), Zurzuvae (postpartum depression, Sage), and Qalsody (ALS, Ionis). Biogen has several drug candidates in phase 3 trials in neurology, immunology, and rare diseases.
About WDC Western Digital Corporation
Western Digital is a leading, vertically integrated supplier of hard disk drives. The HDD market is a practical duopoly with, Western Digital and Seagate being the two largest players. Western Digital designs and manufacturers its HDDs, with much of the manufacturing and workforce located in Asia. The primary consumers of HDDs are data centers.